Social Anxiety Nasal Spray Win; Racemic Ketamine vs Esketamine; Is AI Pro-Anorexia?

— News and commentary from the psychiatry world

MedicalToday
Illustration of a brain shaped maze.

The investigational nasal spray fasedienol significantly improved during a public speaking challenge compared with placebo in the phase III PALISADE-2 trial, said developer Vistagen.

Only about one in five U.S. adults with received any medication to treat it in 2021. (JAMA Network Open)

High-frequency transcranial random noise stimulation plus cognitive training significantly reduced compared with a control intervention in a trial of 23 newly diagnosed, drug-naive children. (Translational Psychiatry)

Greater exposure to air pollutants was tied to among people with dementia -- particularly vascular dementia -- in a retrospective cohort study. (BMJ Mental Health)

When used to treat major depression, racemic ketamine appeared in a meta-analysis of 49 trials. (eClinicalMedicine)

Kids are with more serious mental health issues than ever before. (New York Times)

Florida has "essentially banned" a because of its content on sexuality. (Politico)

Artificial intelligence (AI) programs are . (Washington Post)

More and more psychiatrists are prescribing the to help combat weight gain side effects associated with antipsychotics. (Reuters)

One in five children have , according to data from the CDC's 2021 National Health Interview Survey.

A Georgia State University researcher was awarded a $3.6 million grant to expand for underserved populations in high-need schools.

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.